What is the current Price Target for the Anixa Biosciences, Inc. stock?

The average Anixa Biosciences, Inc. target price is $9.69. This is 248.56% higher than the current stock price. The highest price target is 428.78%, the lowest is 154.32%. 6 Analysts have issued a price target Anixa Biosciences, Inc. 2027 .

How high will the Anixa Biosciences, Inc. stock rise?

No reliable answer can be given as to how high the Anixa Biosciences, Inc. stock will rise. The performance of stocks, including the Anixa Biosciences, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Anixa Biosciences, Inc. stock today?

The performance of Anixa Biosciences, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Anixa Biosciences, Inc. stock fall?

The decline in Anixa Biosciences, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Anixa Biosciences, Inc. Forecast, price target & analysts

$2.78

1.09%

Nasdaq, Sep 24, 04:00 pm EDT. Closed.

ISIN

US03528H1095

Symbol

ANIX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Anixa Biosciences, Inc. Target price 2026 - Analyst rating & recommendation

Anixa Biosciences, Inc. Classifications & Recommendation

Buy

90%

Hold

10%

Anixa Biosciences, Inc. Price Target

Target Price	$9.69
Price	$2.78
Potential	248.56% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Anixa Biosciences, Inc. 2027 . The average Anixa Biosciences, Inc. target price is $9.69. This is 248.56% register free of charge higher than the current stock price. The highest price target is $14.70 428.78% register free of charge , the lowest is $7.07 154.32% register free of charge .
	A rating was issued by 10 analysts: 9 Analysts recommend Anixa Biosciences, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Anixa Biosciences, Inc. stock has an average upside potential 2027 of 248.56% register free of charge . Most analysts recommend the Anixa Biosciences, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Oct '25	2026 Estimates
Earnings Per Share $	-0.34	-0.34
	12.82%	0.00%
P/E		negative

7 Analysts have issued a Anixa Biosciences, Inc. forecast for earnings per share. The average Anixa Biosciences, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-0.34	12.82%
2026	$-0.34 0.00% unlock
2027	$-0.35 2.94% unlock
2028	$-0.39 11.43% unlock
2029	$-0.35 10.26% unlock
2030	$-0.26 25.71% unlock
2031	$0.10 138.46% unlock
2032	$0.71 610.00% unlock
2033	$1.75 146.48% unlock

Current	-8.97	7.61%
2026	-8.12 8.47% unlock
2027	-7.75 4.56% unlock
2028	-7.05 9.03% unlock

Anixa Biosciences, Inc....

Current Anixa Biosciences, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 22 2026
D. Boral Capital	Locked ➜ Locked	Locked	Apr 08 2026
D. Boral Capital	Locked ➜ Locked	Locked	Mar 31 2026
D. Boral Capital	Locked ➜ Locked	Locked	Feb 04 2026
D. Boral Capital	Locked ➜ Locked	Locked	Dec 12 2025
D. Boral Capital	Locked ➜ Locked	Locked	Oct 07 2025
D. Boral Capital	Locked ➜ Locked	Locked	Sep 22 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 22 2026
Locked D. Boral Capital: Locked ➜ Locked	Apr 08 2026
Locked D. Boral Capital: Locked ➜ Locked	Mar 31 2026
Locked D. Boral Capital: Locked ➜ Locked	Feb 04 2026
Locked D. Boral Capital: Locked ➜ Locked	Dec 12 2025
Locked D. Boral Capital: Locked ➜ Locked	Oct 07 2025
Locked D. Boral Capital: Locked ➜ Locked	Sep 22 2025

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 67.67%

Tencent Holdings Ltd. 55.89%

Uber Technologies 48.83%

Siemens Energy 47.15%

Adidas 46.64%

BYD 44.49%

Deutsche Telekom 38.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now